CD47 and endometrial carcinoma: We found that CD47 up-regulation increased PI3K, Akt and mTOR expression in endometrial carcinoma cells (Figures 6A–C), suggesting that CD47 exerted oncogenic effects in endometrial carcinoma via up-regulating the PI3K/Akt/mTOR signaling pathway.